buprenorphine has been researched along with Stomatitis* in 2 studies
2 other study(ies) available for buprenorphine and Stomatitis
| Article | Year |
|---|---|
Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study.
The aim of this study is to ascertain the analgesic efficacy and total oral morphine equivalent daily dose (OMEDD) effect of a buprenorphine-based analgesic protocol in the treatment of severe Oral Mucositis (OM).. This is a retrospective cohort study.. This study was done in a single Quaternary Referral Centre, Haematology Unit.. Fifty-four stem cell transplant patients suffering at least grade 3 oral mucositis (OM), 24 prior to [Pr-I] and 30 subsequent to [Po-I] a buprenorphine-based OM analgesic protocol.. We analysed data from the above subjects with the primary outcome measure of difference in total OMEDDs from all opioid types and administration routes, and secondary outcome measures of area under the curve (AUC) of 11-point Numerical Rating Scale (NRS-11) pain assessments, sedation scores and respiratory rate.. Use of Buprenorphine via transdermal, sublingual and intravenous Patient Controlled Analgesia (PCA) delivery as part of an analgesic protocol for severe post stem cell transplant oral mucositis in adult patients appears to significantly reduce opioid requirements and pain on swallowing. Further randomised prospective work is required to confirm these associations. Topics: Adult; Analgesics, Opioid; Buprenorphine; Deglutition; Humans; Morphine; Pain; Pain Management; Prospective Studies; Retrospective Studies; Stomatitis | 2022 |
Transdermal buprenorphine for oropharyngeal mucositis-associated pain in patients treated with radiotherapy for head and neck cancer.
Topics: Administration, Cutaneous; Buprenorphine; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Narcotics; Oropharynx; Pain; Pain Measurement; Stomatitis | 2010 |